Showing results (11-20 of 22) with videos related to
Sort By:
Pageof 3
European Journal of Haematology|June 1, 2017
Emergence of Bruton's tyrosine kinase-negative Hodgkin lymphoma during ibrutinib treatment of chronic lymphocytic leukaemiaSiobhan Glavey, John Quinn, Mary McCloy, et al.JMIR Formative Research|July 22, 2021
Online Search Trends Influencing Anticoagulation in Patients With COVID-19: Observational StudyAmy P Worrall, Claire Kelly, Aine O'Neill, et al.Plos One|October 21, 2014
Global epigenetic regulation of microRNAs in multiple myelomaWenjing Zhang, Yaoyu E Wang, Yu Zhang, et al.Journal of Thrombosis and Haemostasis : JTH|May 30, 2021
ADAMTS13 regulation of VWF multimer distribution in severe COVID-19Soracha E Ward, Helen Fogarty, Ellie Karampini, et al.Haematologica|March 21, 2024
Steroid-free combination of 5-azacytidine and venetoclax for the treatment of multiple myelomaLyndsey Flanagan, Aisling Coughlan, Nicola Cosgrove, et al.Research and Practice in Thrombosis and Haemostasis|February 23, 2023
Endothelial cell activation, Weibel-Palade body secretion, and enhanced angiogenesis in severe COVID-19Ellie Karampini, Helen Fogarty, Stephanie Elliott, et al.Cell Reports|July 21, 2015
CXCR4 Regulates Extra-Medullary Myeloma through Epithelial-Mesenchymal-Transition-like Transcriptional ActivationAldo M Roccaro, Yuji Mishima, Antonio Sacco, et al.Blood|September 14, 2014
Pyk2 promotes tumor progression in multiple myelomaYu Zhang, Michele Moschetta, Daisy Huynh, et al.Proceedings of the National Academy of Sciences of the United States of America|July 2, 2014
Engineered nanomedicine for myeloma and bone microenvironment targetingArchana Swami, Michaela R Reagan, Pamela Basto, et al.British Journal of Haematology|December 16, 2020
Von Willebrand factor propeptide in severe coronavirus disease 2019 (COVID-19): evidence of acute and sustained endothelial cell activationSoracha E Ward, Gerard F Curley, Michelle Lavin, et al.Pageof 3